This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Abnova
product type :
antibody
product name :
CLEC4E monoclonal antibody, clone AT16E3
catalog :
MAB8479
quantity :
100 uL
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
AT16E3
The same clone is also sold as:
The same clone is also sold as:
- Abcam: ab100846
- MyBioSource: MBS200192
- NKMAX: ATGA0537, ATGA0175
- OriGene: AM09361PU-S, AM09361PU-N
reactivity :
human
application :
western blot, ELISA, immunocytochemistry, immunohistochemistry - paraffin section
product information
catalog id :
MAB8479
product name :
CLEC4E monoclonal antibody, clone AT16E3
product description :
Mouse monoclonal antibody raised against partial recombinant CLEC4E.
clone name :
AT16E3
isotype :
IgG2b, kappa
gene name :
CLEC4E
gene alias :
CLECSF9 MINCLE
gene description :
C-type lectin domain family 4, member E
immunogen :
Recombinant protein corresponding to amino acids 41-219 of human CLEC4E.
protein accession :
NP_055173
form :
Liquid
recommend dilutions :
ELISA (1:250). Western Blot (1:250-1:500). Immunofluorescence (1:250-1:500). The optimal working dilution should be determined by the end user.
storage buffer :
In PBS, pH 7.4 (0.02% sodium azide, 10% glycerol)
storage instruction :
Store at 4 C short term. For long term storage store at -20 C. Aliquot to avoid repeated freezing and thawing.
note :
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
type clonality :
Antibody
raised in host species :
Mouse
antigen species target species :
Human
species reactivity cross reactivity :
Human
application key :
ELISA,WB-Ce,IHC-P,IF
size :
100 uL
autodate :
2010-11-01
updatetime :
2017-03-02 09:57:59
company information
Abnova
9th Fl., No.108, Jhouzih St.
Neihu District. Taipei City
114 Taiwan
Neihu District. Taipei City
114 Taiwan
sales@abnova.com
https://www.abnova.com877-853-6098
questions and comments